Press Releases
WILMINGTON, Del., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, January 28, 2025. The company’s live webcast with securities analysts will include an executive summary
Wilmington, Del., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in the calendar first quarter 2025, subject to the satisfaction of customary closing
Company to hold investor strategy update event on December 10, 2024 Wilmington, Del., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Participating in a tradition that has evolved since 1792, today, employees from Ashland Inc. (NYSE: ASH) gathered on the floor of the New York Stock Exchange as Guillermo Novo,
Wilmington, Del., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), the global additives and specialty ingredients company today announced a strategic partnership with the Arbor Day Foundation, recognizing the 100-year anniversary of the company and celebrating the innovative work of its
WILMINGTON, Del., Nov. 14, 2024 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. The dividend is payable on December 15, 2024, to stockholders of record at the close of business on
WILMINGTON, Del., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a strategy update event for analysts and investors on Tuesday, December 10, 2024, in New York City. The company will provide an in-depth review of Ashland’s strategic priorities, key initiatives and financial
Financial results for fourth-quarter fiscal 2024 1 Sales of $522 million, up one percent from the prior-year quarter Sold nutraceuticals business to Turnspire Capital Partners LLC Previously announced carboxymethylcellulose (CMC), methylcellulose (MC) and nutraceuticals portfolio optimization
Wilmington, Del., October 31, 2024 – Ten years ago, Ashland pioneered epigenetic research harnessing the power of skin microRNA and plant small RNA into botanicals and peptides to deliver outstanding skin benefits. Today Ashland is in good company with Victor Ambros and Gary Ruvkun, two American
WILMINGTON, Del., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2024 earnings release at approximately 5 p.m. ET on Wednesday, November 6, 2024. The company’s live webcast with securities analysts will include an executive
Wilmington, Del., Oct. 2, 2024 – Ashland is showcasing two new life sciences products during upcoming tradeshows, CPHI Milan, October 8-10 (booth 6D20) and AAPS PharmSci 360 in Salt Lake City, UT, October 20-23 (booth 1903).